Insider Trading History of Patton Stephana Eilene

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Patton Stephana Eilene since 2017. The trader's CIK number is 1698237. At the time of the last reporting, Patton Stephana Eilene was the General Counsel of Eiger Biopharmaceuticals, Inc.. (stock ticker symbol EIGR). Also see all insider trading activities at Eiger Biopharmaceuticals, Inc..

Note that in the past Patton Stephana Eilene also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eiger Biopharmaceuticals, Inc. (EIGR) by Patton Stephana Eilene

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 EIGR 1,000 $11,030 0 $0 0 $0

Yearly summary of insider trading at Lineage Cell Therapeutics, Inc. (BTX) by Patton Stephana Eilene

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 BTX 0 $0 0 $0 41,250 $0
2017 BTX 7,500 $19,380 0 $0 0 $0


Insider trading activities at 2 companies by Patton Stephana Eilene:

1. Eiger Biopharmaceuticals, Inc. (EIGR)

2. Lineage Cell Therapeutics, Inc. (BTX)

Table 1. Insider trading of Eiger Biopharmaceuticals, Inc. (EIGR) by Patton Stephana Eilene

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-04-22 EIGR Buy 1,000 11.03 11,030

Table 2. Insider trading of Lineage Cell Therapeutics, Inc. (BTX) by Patton Stephana Eilene

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-12-18 BTX Option Ex 27,500 .00 0
2018-10-04 BTX Option Ex 13,750 .00 0
2017-08-21 BTX Buy 7,500 2.58 19,380

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patton Stephana Eilene (General Counsel of Eiger Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.